, in the stroma endothelial suspensions of six corneas (9*8%), and in the storage media of five corneas (8.2%). HBVcDNA was detected for the first time in the cornea; in the epithelium of four corneas (6-6%), stroma endothelium of nine corneas (148%), and the storage media of five corneas (8/2%). The control corneas were negative for HBsAg, while HBVcDNA was detected in the stroma endothelium oftwo corneas (10%) and in the media of two corneas (10%). This study confirmed that HBV can be present in the human cornea. Preservation in corneal storage media for up to 6 days could not eliminate the virus from the cornea. The possibility of HBV transmission through corneal transplantation should not be overlooked. (BrJ Ophthalmol 1995; 79: 6-9) 
enzyme linked immunosorbent assay (ELISA) and for the presence of hepatitis B virus core DNA (HBVcDNA) using the hybridisation technique in their epithelium, stroma endothelium, and storage media. HBsAg was detected by ELISA in the epithelium ofone cornea (I 606%), in the stroma endothelial suspensions of six corneas (9*8%), and in the storage media of five corneas (8.2%). HBVcDNA was detected for the first time in the cornea; in the epithelium of four corneas (6-6%), stroma endothelium of nine corneas (148%), and the storage media of five corneas (8/2%). The control corneas were negative for HBsAg, while HBVcDNA was detected in the stroma endothelium oftwo corneas (10%) and in the media of two corneas (10%). This study confirmed that HBV can be present in the human cornea. Preservation in corneal storage media for up to 6 days could not eliminate the virus from the cornea. The possibility of HBV transmission through corneal transplantation should not be overlooked.
(BrJ Ophthalmol 1995; 79: [6] [7] [8] [9] Transmission of donor disease to Before the results of serum testing five corneoscleral rims were preserved in 20 ml of Dexsol medium and 76 in 20 ml of McCareyKaufman (MK) medium. Both media were supplied by Chiron Ophthalmics (California, USA). All specimens were kept in the CUEB refrigerator at 40C until seropositivity was confirmed.
All specimens were manipulated with sterile gloves in the chamber of a laminar airflow apparatus. The bottle was opened, the corneoscleral button was held using a fixation forceps, removed from the bottle, washed with saline solution, and placed (epithelial side up) in a sterile petri dish. Using the fixation forceps and scissors, the scleral rim was excised and thrown away. With the cornea firmly held down on the petri dish, the epithelium was scraped with No 11 surgical blade, then washed from the The epithelial scrapings of one cornea (1 6%) tested positive for HBsAg using ELISA, while those of another four corneas (6-6%) taken from four donors tested positive for HBVcDNA (Table 1) .
The stroma endothelial suspensions of six corneas (9.8%) taken from four donors were found positive for HBsAg using ELISA, while those of nine corneas (14-8%) taken from five donors were positive for HBVcDNA (Table 1) . Of the above, three stroma endothelial suspensions from two donors were positive for both HBsAg and HBVcDNA. These positive corneas remained in their preservative media for [1] [2] [3] [4] [5] [6] days.
The preservative media of five corneas (8-2%) taken from four donors were positive for HBsAg using ELISA. Of these, four were MK and one was Dexsol. One MK medium contained the cornea for just 1 Of the 51 corneas preserved in media which were negative for both markers, the epithelial suspension of one cornea was positive for HBsAg and those of another three corneas were positive for HBVcDNA, one stroma endothelial suspension tested positive only for HBsAg, three tested positive only for HBVcDNA, and two tested positive for both markers. A total of 10 corneas gave positive results.
Of the 20 control corneas obtained from HBsAg seronegative donors, no tissue suspension or medium was positive for HBsAg. The stroma endothelium of two corneas taken from the same donor and the preservative media of another two corneas of two different donors were positive for HBVcDNA ( Table 2 ). Both of these media were MK.
Discussion
Since the discovery of the possibility of transmission of some viral diseases through corneal transplantation, it has been questioned whether or not transmission of HBV infection could possibly occur in the same way.
HBsAg was previously detected in tears,3 [11] [12] [13] aqueous,7 12 13 subretinal fluid, '4 conjunctiva, corneal epithelium, and uveal tissue.7 While this antigen is located on the infectious virus envelope, it is also found on non-infectious particles.8 Owing to a better understanding of the nature of this virus and to the use of viral DNA as a marker of complete replicative forms, it is now possible to confirm the state of HBV infectivity in tissues.9 15 The hybridisation technique used for HBVDNA detection is highly sensitive. 16 17 It has been used successfully to detect HBV DNA sequences in different minced tissues. 6 10 In this study, HBsAg could be detected in none of the corneal samples using RPHA HBsAg has been detected previously using ELISA in emulsified whole corneas of a seropositive donor.2 The positive result could be caused by the presence of HBsAg in the epithelium, stroma, endothelium, or contamination of the endothelial surface from adjacent aqueous. In the current study, however, emulsification was carried out after epithelial scraping followed by washing of both epithelial and endothelial surfaces. Hence, the possibility of viral adherence to the endothelium from adjacent aqueous is minimal. As no attempt was made to separate endothelium from stroma, these positive results may reflect the presence of the virus in endothelium, stroma, or both. As no vascularised corneas were used in the study, the possibility of blood contaminating the samples is unlikely. The occurrence of more positive results for both markers in the stroma endothelial samples than epithelial samples may be attributed to different dilution standards used for both samples. In the mean time, the occurrence of more overall positive results with HBVcDNA than with HBsAg may reflect the higher sensitivity of molecular hybridisation over other serological tests including ELISA used to detect HBsAg. In one report HBV DNA was detected in 65-2% of samples negative to HBsAg by RPHA.16
Detection of viral markers in the preservative media is probably due to diffusion from the corneal tissue. However, presence of blood traces in the media might be another cause, although blood was not evident grossly in any of the samples.
Of the 10 corneas preserved in media which tested positive for either marker, six corneas were positive for HBsAg, HBVcDNA, or both in their tissues, while four were negative for both markers. Of the 51 corneas preserved in media which tested negative for both markers, 10 corneas were positive for HBsAg, HBVcDNA, or both in their tissues. So, it is likely that four out of 10 corneas became negative after diffusion of their markers to their storage media. Of these four corneas, one remained in its medium for only 1 day. On the other hand, viral markers in 10 positive corneas failed to diffuse to the surrounding medium in detectable levels, although some of them were kept in their media for up to 6 days. Thus, the storage medium did not have a hypothesised beneficial effect in diluting the virus particles, even with prolonged preservation (up to 6 days). The duration of storage was irrelevant to diffusion of markers to the medium.
The presence of positive results for HBVcDNA in three out of 12 HBsAg seronegative donors may be explained by real absence of HBsAg from the circulation in one stage of the disease (window phase). Alternatively, it can reflect a false negative result associated with latex agglutination. It is also probable that the serum of these seronegative donors did contain amounts of HBsAg too small to be detected by that test. Consequently, HBsAg could not reach detectable levels in their corneas. However, HBVcDNA could be detected with the more sensitive hybridisation technique in the corneas. Probably, these donors and one or more HBsAg seronegatives would be seropositive for HBVcDNA.
Transmission of HBV infection via the conjunctival route can occur as shown by the experimental inoculation of infectious material into the conjunctival sac of a chimpanzeel8 and the possible transmission of the disease to a nurse who had a splash of infective blood onto her eyes.19 This study detected that not only the surface antigen but also the viral DNA itself could be present in corneal tissues prepared for surgery, even after storing them for up to 6 days in corneal storage medium. To our knowledge, this is the first published work to search for and document the presence of HBVDNA in the cornea. The conditions of tissues used in this study were nearest to surgical conditions; no vascularised corneas were used, scleral rims were excised, no attempt was made to separate endothelium from stroma, corneoscleral buttons were taken from apparently healthy donors, jaundice was present in only one donor, who oddly did not show any positive results.
While three of 12 donors seronegative for HBsAg were positive for core DNA in corneal tissue/media, there were no cases reported to CUEB of possible transmission of clinical hepatitis after corneal grafting. An unanswered question is whether the amount of the virus present in the tissue constitutes an infectious inoculum when introduced through the eye. What is infectious by a certain route might not be so by another route. Infectious saliva could transmit hepatitis when administered subcutaneously to gibbons, but the same material failed to infect the animals when administered orally.20 21 Is the amount of the virus present in the cornea so small that it can not introduce infection through the eye which probably needs such a high concentration for the infection to be transmitted? Noteworthy too is the fact that despite the presence of HIV in the cornea,22 its transmission through corneal transplantation could not be documented with many inadvertent transplantations from seropositive to seronegative recipients.23 24 However, until these questions are answered, eye banks should continue the current policy, of rejecting tissues of any donor who proves to be HBsAg seropositive. Great 
